OverviewChartNewsTraderScreen

Morgan Stanley Discount Zert MRNA.../  DE000ME5BRC6  /

Stuttgart
27/05/2024  21:51:01 Chg.-1.59 Bid22:00:32 Ask22:00:32 Underlying Strike price Expiration date Option type
58.25EUR -2.66% -
Bid Size: -		 -
Ask Size: -		 Moderna Inc - USD 28/06/2024 Call
GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 22/05 Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
TeleTrader 20/05 Dow slumps 195 points at closing bell after corporate news
GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants
TeleTrader 13/05 Wall Street closes mixed ahead of key inflation data
GlobeNewswire 12/05 TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
TeleTrader 02/05 US surges at close as traders weigh Fed remarks
TeleTrader 02/05 Moderna surges 9% as Q1 revenue beat expectations
GlobeNewswire 02/05 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
TeleTrader 02/05 Moderna sees $167M in Q1 revenue, beats forecasts
TeleTrader 02/05 US higher premarket after Fed's decision
GlobeNewswire 01/05 Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
GlobeNewswire 01/05 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
TeleTrader 24/04 Moderna, OpenAI partner on mRNA medicine advancement
TeleTrader 09/04 US markets close mostly higher ahead of inflation report
GlobeNewswire 04/04 Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...
TeleTrader 28/03 US closes mixed amid data
TeleTrader 26/03 Wall Street closes lower after economic data
GlobeNewswire 21/03 Immatics Announces Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 11/03 CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update
GlobeNewswire 04/03 CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
GlobeNewswire 29/02 Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
GlobeNewswire 27/02 CytomX Therapeutics to Present at Upcoming March Investor Conferences